awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q54403335-63D8E596-7434-4784-8129-273282C3881D
Q54403335-63D8E596-7434-4784-8129-273282C3881D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54403335-63D8E596-7434-4784-8129-273282C3881D
Phase II trial of erlotinib in patients with advanced non‑small‑cell lung cancer harboring epidermal growth factor receptor mutations: additive analysis of pharmacokinetics.
P2860
Q54403335-63D8E596-7434-4784-8129-273282C3881D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54403335-63D8E596-7434-4784-8129-273282C3881D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0240c737098250129a21d1b5dc45dcbb24ab1d21
P2860
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.